Application of Adverse Outcome Pathways to U.S. EPA’s Endocrine Disruptor Screening Program
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The U.S. EPA's Endocrine Disruptor Screening Program (EDSP) screens and tests environmental chemicals for potential effects in estrogen, androgen, and thyroid hormone pathways, and it is one of the only regulatory programs designed around chemical mode of action. OBJECTIVES: This review describes the EDSP's use of adverse outcome pathway (AOP) and toxicity pathway frameworks to organize and integrate diverse biological data for evaluating the endocrine activity of chemicals. Using these frameworks helps to establish biologically plausible links between endocrine mechanisms and apical responses when those end points are not measured in the same assay. RESULTS: Pathway frameworks can facilitate a weight of evidence determination of a chemical's potential endocrine activity, identify data gaps, aid study design, direct assay development, and guide testing strategies. Pathway frameworks also can be used to evaluate the performance of computational approaches as alternatives for low-throughput and animal-based assays and predict downstream key events. In cases where computational methods can be validated based on performance, they may be considered as alternatives to specific assays or end points. CONCLUSIONS: A variety of biological systems affect apical end points used in regulatory risk assessments, and without mechanistic data, an endocrine mode of action cannot be determined. Because the EDSP was designed to consider mode of action, toxicity pathway and AOP concepts are a natural fit. Pathway frameworks have diverse applications to endocrine screening and testing. An estrogen pathway example is presented, and similar approaches are being used to evaluate alternative methods and develop predictive models for androgen and thyroid pathways. https://doi.org/10.1289/EHP1304.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., et al. (2009) · Environmental Toxicology and Chemistry · doi:10.1002/etc.34 · Cited by 2,734
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407 · cited 2×
“A chemical binding and activating the ER may be linked to adverse effects such as reduced fertility and fecundity as well as declining population trajectories (Groh et al. 2015; Ankley et al. 2010).”
BackgroundScreening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model
Browne, P., Judson, R. S., Casey, W. M., Kleinstreuer, N. C., & Thomas, R. S. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b02641 · Cited by 276
Self-citationWittwehr, C., Aladjov, H., Ankley, G., Byrne, H. J., de Knecht, J., Heinzle, E., Klambauer, G., Landesmann, B., Luijten, M., MacKay, C., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw207 · Cited by 161 · cited 3×
“However, AOPs provide a systematic approach for organizing available information and supporting inferential links between mechanisms and adverse effects (Wittwehr et al. 2017), and they help to create plausible, causal links between data derived from varied sources.”
BackgroundInfluentialTest driving ToxCast: endocrine profiling for 1858 chemicals included in phase II
Filer, D., Patisaul, H. B., Schug, T., Reif, D., & Thayer, K. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.021 · Cited by 71
Cited by
Ankley, G. T., Cureton, P., Hoke, R. A., Houde, M., Kumar, A., Kurias, J., Lanno, R., McCarthy, C., Newsted, J., Salice, C. J., et al. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4869 · Cited by 454
Endocrine Disrupting Chemicals: Effects on Endocrine Glands
Lauretta, R., Sansone, A., Sansone, M., Romanelli, F., & Appetecchia, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00178 · Cited by 340
Ciallella, H. L., & Zhu, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00393 · Cited by 227
“107 Currently, AOPs are being developed for various types of toxicities such as acute inhalation toxicity, 108 neurotoxicity, 109–111 skin sensitization, 112–114 estrogen receptor bindings, 115,116 forestomach tumors not induced by genotoxic events, 117 and drug-induced cholestatic liver injury.”
BackgroundEndocrine-disrupting chemicals exposure: Cardiometabolic health risk in humans
Ma, C.-X., Ma, X.-N., Li, H.-L., Mauricio, D., & Fu, S.-B. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02938-8 · Cited by 19
Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities
Shah, I., Bundy, J., Chambers, B., Everett, L. J., Haggard, D., Harrill, J., Judson, R. S., Nyffeler, J., & Patlewicz, G. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00245 · Cited by 19
Metadata
- Authors
- Browne, P., Noyes, P. D., Casey, W. M., & Dix, D. J.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-09-22
- Volume
- 125
- Issue
- 9
- Pages
- 096001-096001
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2756846467
- Cited by
- 141
- References
- 5
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Application of Adverse Outcome Pathways to U.S. EPA’s Endocrine Disruptor Screening Program. https://app.cochat.ai/papers/10.1289/ehp1304
- The paper
- Browne, P., Noyes, P. D., Casey, W. M., & Dix, D. J. (2017). Application of Adverse Outcome Pathways to U.S. EPA’s Endocrine Disruptor Screening Program. Environmental Health Perspectives. https://doi.org/10.1289/ehp1304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.